Molecular Therapy Oncology
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Cancer Research
Q1
└
Molecular Medicine
Q1
└
Oncology
Q1
Publisher
SJR 2025
1.790
Q1
SJR Score
H-Index
57
Citations / Doc (2yr)
4.22
Total Docs. (latest)
159
Total Citations (3yr)
1,956
Publication type
Journals
ISSN
29503299
Coverage
2024-2026
Journal Rank
#1,765
Subject Categories
Cancer Research
Q1
Molecular Medicine
Q1
Oncology
Q1
Pharmacology (medical)
Q1
Subject Areas
Aims & Scope
Molecular Therapy Oncology is an international, online-only, open-access journal focusing on the development and testing of cancer therapies in pre-clinical and clinical settings.
While providing a unique forum for work in the burgeoning fields of biologic cancer therapies including viral, bacterial, cellular, and gene therapy, the journal will consider all top-quality, cutting-edge research that employs innovative approaches to cancer treatment.
The scope also encompasses the identification and validation of predictive biomarkers of response.
Because the journal is focused on cancer therapies, most accepted papers will have translational relevance.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Embase
Detailed Metrics
| Total Docs. (latest) | 159 |
| Total Docs. (3 years) | 387 |
| Total Refs. | 8,532 |
| Total Citations (3 years) | 1,956 |
| Citable Docs. (3 years) | 340 |
| Citations / Doc. (2 years) | 4.22 |
| Ref. / Doc. | 53.66 |
| % Female | 46.5% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Molecular Therapy Oncology?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Molecular Therapy Oncology has an SJR of 1.790 and is ranked Q1.
What is the SJR and quartile of Molecular Therapy Oncology?
Molecular Therapy Oncology has an SJR (SCImago Journal Rank) of 1.790 and its best quartile is Q1.
What is the H-index of Molecular Therapy Oncology?
The H-index of Molecular Therapy Oncology is 57, meaning 57 of its articles have each been cited at least 57 times.
Is Molecular Therapy Oncology indexed in Scopus?
Yes. Molecular Therapy Oncology is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.